Skip to main content
Caplight Logo









Phenex Pharmaceuticals AG

Phenex Pharmaceuticals AG

Private
HeidelbergHealthcare & Life Scienceshttp://phenex-pharma.com/

Last Round

M&A

Jan 6, 2015

Total Funding Raised

$19.6M

Company Overview

Phenex Pharmaceuticals AG is a biotechnology company that specializes in the discovery and development of small-molecule drugs for liver, gastrointestinal, and cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

small-molecule drug discoverybiotechnologynuclear receptorsdrug discovery servicesmedicinal chemistrybiotech R&Ddrug licensingmetabolic disease researchoncology researchpreclinical developmenttherapeutic targetspharma partneringdrug pipelinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Phenex Pharmaceuticals AG Comparables

Compare Phenex Pharmaceuticals AG with similar companies based on industry and business-model similarity.

Phenex Pharmaceuticals AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Lead Pharma
84%
Orphagen Pharmaceuticals
83%
WMT AG
78%

Phenex Pharmaceuticals AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
M&AJan 6, 2015
Series CSep 21, 2010
Series BOct 2, 2008

Phenex Pharmaceuticals AG Investors

Notable investors and investment history

Phenex Pharmaceuticals AG investors
InvestorRounds
CD-VentureSeries C
Creathor VentureSeries B
KfW Development BankSeries B, Series C
LBBW Venture CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 6, 2015

    $470M round led by Gilead Sciences

  • Sep 21, 2010

    Raised $8M from LBBW Venture Capital, Swiss Life, and others.

Phenex Pharmaceuticals AG Filings

Explore SEC and related filing metadata, where available.

Phenex Pharmaceuticals AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Phenex Pharmaceuticals AG's valuation, stock price, and market status.

Is Phenex Pharmaceuticals AG a public or private company?

Phenex Pharmaceuticals AG is a private company.

What is the current stock price of Phenex Pharmaceuticals AG?

Phenex Pharmaceuticals AG is a private company with no public stock price. No recent secondary market data is available.

How much is Phenex Pharmaceuticals AG worth (valuation)?

Valuation information for Phenex Pharmaceuticals AG is not publicly available.

Can I buy Phenex Pharmaceuticals AG stock?

Phenex Pharmaceuticals AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Phenex Pharmaceuticals AG's last funding round?

Phenex Pharmaceuticals AG's most recent funding round was M&A on January 6, 2015.

Who are the main investors in Phenex Pharmaceuticals AG?

Key investors in Phenex Pharmaceuticals AG include Creathor Venture.

Will Phenex Pharmaceuticals AG IPO soon?

No public IPO plans have been announced for Phenex Pharmaceuticals AG.

How can I track Phenex Pharmaceuticals AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phenex Pharmaceuticals AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHeidelberg
Employee Range5
Year Founded2002
Last FundingJan 6, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?